Medical marijuana has been one of the most effective and versatile treatments for a variety of diseases for decades. Recently, a number of U.S. states added new conditions to their lists of acceptable illnesses to receive such treatments. In Minnesota, sleep apnea patients can now turn to medical marijuana. Michigan also updated its list to include an additional 11 health issues such as autism.
After soliciting public comments as well as reviewing the scientific evidence on hand, the Minnesota Department of Health decided to allow medical marijuana as a treatment for sleep apnea, KSTP reports. This decision was also made after a review panel by citizens was hosted to ensure that the local populace was onboard.
However, not everyone is thrilled about this decision, with some health experts stating that medical marijuana is not as effective in treating the condition as conventional medical treatments. Sleep apnea expert Dr. Jonathan Parker is one such voice to express concern that the development could lead to negative consequences.
Aside from Minnesota, Michigan also decided to update its list of acceptable medical conditions that could receive medical marijuana treatment. These conditions include Parkinson’s disease, chronic pain, and Tourette’s syndrome, the Detroit Free Press reports. The state even threw in autism into the mix for good measure.
In order to make use of medical marijuana, however, patients will need a medical marijuana card. The card must be approved by a doctor and will cost $60.
With these new diseases on the list, the items have now gone up to 22 acceptable ailments. However, even as the state approved the 11 health conditions, it also rejected 11 others. The diseases that were not deemed acceptable to receive medical marijuana treatment include depression, panic attacks, and asthma. That last part might have been the most understandable, however, since it is a respiratory condition.


FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Is dark chocolate healthier than milk chocolate? 2 dietitians explain
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint
CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship
Why the future of marijuana legalization remains hazy despite high public support
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
RFK Jr. Expands CDC Vaccine Advisory Panel's Scope Amid Legal Battles
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
Intermittent fasting doesn’t have an edge for weight loss, but might still work for some
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand 



